Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
02/2014
02/11/2014CA2559187C Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
02/11/2014CA2553943C Oxidative reductive potential water solution, processes for producing same and methods of using the same
02/11/2014CA2551749C Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
02/11/2014CA2549593C Stabilised compositions of factor vii polypeptides
02/11/2014CA2529496C Anti-cd74 immunoconjugates and methods
02/11/2014CA2499214C Stable immunogenic product comprising antigenic heterocomplexes
02/11/2014CA2498502C Recombinant clostridial toxin fragments with proteolytic activation
02/11/2014CA2493806C Aqueous iron carbohydrate complexes, their production and medicaments containing them
02/11/2014CA2472401C Improved method of production of lycopene by the fermentation of selected strains of blakeslea trispora, formulations and uses of the lycopene obtained
02/11/2014CA2471363C Albumin fusion proteins
02/11/2014CA2469266C The method of treating cancer
02/11/2014CA2466632C Injectable depot compositions and uses thereof
02/11/2014CA2421751C Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
02/11/2014CA2388045C Nucleic acid immunogenic compositions encoding hsp-antigen chimera
02/11/2014CA2364500C Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
02/11/2014CA2357986C Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
02/06/2014WO2014022760A1 Method and kit for bowel preparation
02/06/2014WO2014022749A1 Porous electrolytic polymer cryogels for enhanced electrical collapsibility
02/06/2014WO2014022720A1 Polymer conjugates for delivery of biologically active agents
02/06/2014WO2014022685A1 Recruitment of mesenchymal cells using controlled release systems
02/06/2014WO2014022679A2 Anti-etbr antibodies and immunoconjugates
02/06/2014WO2014022515A1 Dephosphorylated lysosomal storage disease proteins and methods of use thereof
02/06/2014WO2014022271A1 Method of treating metastatic cancer
02/06/2014WO2014021678A1 Microbubble-nanoliposome complex for cancer diagnosis and treatment
02/06/2014WO2014021393A1 Transdermal absorption-type pharmaceutical preparation comprising zonisamide
02/06/2014WO2014021284A1 Anti-trichophytic adhesive patch
02/06/2014WO2014021282A1 Antitrichophytosis solution for external use
02/06/2014WO2014020610A1 Compositions and methods for the treatment of bone voids and open fractures
02/06/2014WO2014020366A1 Transdermal formulation containing cox inhibitors
02/06/2014WO2014020344A1 Compounds and their effects on appetite control and insulin sensitivity
02/06/2014WO2014019972A1 Injectable compositions comprising letrozole or anastrozole
02/06/2014WO2014019971A1 Peptides comprising a short-chain polyethylene glycol moiety
02/06/2014WO2014019830A1 Transport of photosensitizing substances using immune cells for tumour treatment
02/06/2014WO2014019556A1 Alaptide : methods of effecting its solubility, membrane permeation and pharmaceutical compositions for human and/or veterinary applications
02/06/2014WO2014019555A1 Vesicles which include epidermal growth factor and compositions that contain same
02/06/2014WO2014019095A1 Resiniferatoxin solution
02/06/2014WO2014019082A1 Surface modified nanocrystalline cellulose and uses thereof
02/06/2014WO2013188755A3 Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo
02/06/2014WO2013188279A8 Topical ophthalmological pharmaceutical composition containing cediranib
02/06/2014US20140039205 Method for Preparing Branched Functionalized Polymers Using Branched Polyol Cores
02/06/2014US20140039167 Polymer Derivatives Comprising an Acetal or Ketal Branching Point
02/06/2014US20140039125 Polymalic acid-based multifunctional drug delivery system
02/06/2014US20140039070 Compositions and methods of delivery of pharmacological agents
02/06/2014US20140039069 Compositions and methods of delivery of pharmacological agents
02/06/2014US20140039068 Drug Delivery Compositions and Methods
02/06/2014US20140039061 Hyaluronic acid composition
02/06/2014US20140039058 Ophthalmic solution
02/06/2014US20140039046 Compositions and products containing s-equol, and methods for their making
02/06/2014US20140039039 Organic compositions to treat hsf1-related diseases
02/06/2014US20140039034 Composition for suppressing expression of target gene
02/06/2014US20140039032 Lipid nano particles comprising cationic lipid for drug delivery system
02/06/2014US20140039030 Polymer-des-ethyl sunitinib conjugates
02/06/2014US20140039017 Therapeutic combination
02/06/2014US20140039005 Novel rebamipide complexes and cocrystals
02/06/2014US20140039000 Liquid pharmaceutical formulations of palonosetron
02/06/2014US20140038996 Freeze Dried Drug Nanosuspensions
02/06/2014US20140038992 Methods of administering raltegravir and raltegravir compositions
02/06/2014US20140038931 Method for producing a composite organic compound powder for medical use
02/06/2014US20140038917 Sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
02/06/2014US20140038894 A polymeric nanoparticle
02/06/2014US20140038892 Conjugates Of Carboxy Polysaccharides With Fibroblast Growth Factors And Variants Thereof
02/06/2014US20140038891 Modified exendins and exendin agonists
02/06/2014US20140038886 Hydrophobic modified peptides and their use for liver specific targeting
02/06/2014US20140038879 Surface induced disassembly of nano containers
02/06/2014US20140037775 Method and Kit for Bowel Preparation
02/06/2014US20140037769 Method for manufacturing pure guar flour
02/06/2014US20140037759 Antacid Tablet
02/06/2014US20140037746 Polymer-based, sustained release drug delivery system
02/06/2014US20140037738 Transdermal formulation containing cox inhibitors
02/06/2014US20140037736 Targeting of Antigen Presenting Cells With Immunonanotherapeutics
02/06/2014US20140037735 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
02/06/2014US20140037722 Methods and compositions of camel derived products
02/06/2014US20140037714 Amino acid lipids and uses thereof
02/06/2014US20140037708 Composition for spatio and/or temporal release of bioactive material
02/06/2014US20140037697 Particulate materials
02/06/2014US20140037695 Compositions and methods for targeting of treating neoplasms
02/06/2014US20140037684 Stabilizing excipient for inactivated whole virus vaccine
02/06/2014US20140037633 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
02/06/2014US20140037611 Treatment of Pompe's Disease
02/06/2014US20140037588 Injectable thermoresponsive polyelectrolytes
02/06/2014US20140037554 Cupredoxin derived transport agents and methods of use thereof
02/06/2014US20140037540 Compositions against cancer antigen liv-1 and uses thereof
02/06/2014US20140035184 Extended release biodegradable ocular implants
02/06/2014DE102012015248A1 Verfahren zur Einbringung biologisch aktiver Substanzen ins Gehirn Method for introducing biologically active substances into the brain
02/05/2014EP2692742A1 Novel preparation technique for higher-order structure that exhibits anti-cellular effect
02/05/2014EP2692730A1 Site-directed mono-substituted pegylated exendin analog and preparation method therefor
02/05/2014EP2692361A1 Peptides comprising a short-chain polyethylene glycol moiety
02/05/2014EP2692360A1 Fat emulsion containing prostaglandin
02/05/2014EP2692347A1 Ointment with excellent formulation stability
02/05/2014EP2692340A1 Stable pharmaceutical system (kit) for the preparation of oral solution of levothyroxine or pharmaceutically acceptable salt thereof
02/05/2014EP2692337A1 Film-shaped externally used drug composition
02/05/2014EP2692336A1 Externally used drug kit
02/05/2014EP2692334A1 Vesicle composition
02/05/2014EP2692331A1 Carotenoid-containing composition and method for producing same
02/05/2014EP2691155A2 Preparation of maytansinoid antibody conjugates by a one-step process
02/05/2014EP2691120A2 Theranostic imaging agents and methods of use
02/05/2014EP2691119A1 Pharmaceutical preparation
02/05/2014EP2691118A2 Perfluorinated compounds for the non-viral transfer of nucleic acids
02/05/2014EP2691117A2 Process for manufacturing conjugates of improved homogeneity
02/05/2014EP2691116A1 Nanoparticles loaded with chemotherapeutic antitumoral drug
1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 1712